ScinoPharm Taiwan Ltd
ScinoPharm Taiwan's GHG Emissions Data Preview
In 2023, ScinoPharm Taiwan completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, ScinoPharm Taiwan has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2023 | 2022 | 2021 | 2020 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Verified Sources Behind ScinoPharm Taiwan’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore ScinoPharm Taiwan’s data sources below and access millions more through our Disclosure Search.
Insights into ScinoPharm Taiwan's Operational Emissions
In 2023, the total operational greenhouse gas (GHG) emissions of ScinoPharm Taiwan amounted to 21,360.51 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2022, the total operational greenhouse gas (GHG) emissions of ScinoPharm Taiwan increased by 10.63%, suggesting that the company faced challenges in reducing its emissions from its core operations. a
ScinoPharm Taiwan's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are ScinoPharm Taiwan's Scope 1 emissions?
In 2023, the total Scope 1 emissions of ScinoPharm Taiwan were 4,292.54 metric tons of CO₂ equivalent (tCO₂e). a
Has ScinoPharm Taiwan reduced its Scope 1 emissions over time?
Since 2020, ScinoPharm Taiwan's Scope 1 emissions have increased by 61.5%, reflecting a rising long-term trend in Scope 1 emissions over time. a b
Compared to the previous year (2022), ScinoPharm Taiwan's Scope 1 emissions increased by 31.56%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations. a
What are ScinoPharm Taiwan's Scope 2 emissions?
In 2023, ScinoPharm Taiwan reported Scope 2 greenhouse gas (GHG) emissions of 17,067.97 tCO₂e without specifying the calculation method. a
Has ScinoPharm Taiwan reduced its Scope 2 emissions over time?
Since 2020, ScinoPharm Taiwan's Scope 2 greenhouse gas (GHG) emissions ( Unspecified Calculation Method) have decreased by 17.32%, reflecting a declining long-term trend in Scope 2 emissions over time. a b
Compared to the previous year (2022), ScinoPharm Taiwan's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that ScinoPharm Taiwan 's emissions have plateaued with no significant change in its energy consumption footprint. a
What methodology does ScinoPharm Taiwan use for Scope 2 reporting?
In 2023, ScinoPharm Taiwan reported its Scope 2 emissions using an unspecified methodology. a
ScinoPharm Taiwan's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)
Insights into ScinoPharm Taiwan’s GHG Emissions Intensity Compared to Industry Peers
In 2023, ScinoPharm Taiwan reported Scope 1 greenhouse gas (GHG) emissions of 4,292.54 tCO₂e and total revenues of USD 104 millions. This translates into an emissions intensity of 41.33 tCO₂e per millions USD. a
ScinoPharm Taiwan's Scope 1 Emissions Intensity Compared to Peers
How does ScinoPharm Taiwan's GHG emissions intensity compare to its peers?
In 2023, ScinoPharm Taiwan reported a Scope 1 emissions intensity of 41.33 tCO₂e per millions USD. Compared to the peer group median of 14.62 , this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors. a
Where does ScinoPharm Taiwan rank on GHG emissions intensity within its industry?
In 2023, ScinoPharm Taiwan ranked 18 out of 21 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
This places ScinoPharm Taiwan among the least efficient performers, with one of the highest emissions intensities in its sector. a